Clinical Features and Long-Term Prognosis in Young Patients With Acute Myocardial Infarction
Launched by CHINA-JAPAN FRIENDSHIP HOSPITAL · Aug 14, 2025
Trial Information
Current as of September 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is looking at heart attacks (called acute myocardial infarctions) in young adults between the ages of 18 and 45. The goal is to better understand the unique features and risk factors that affect younger people who have heart attacks, since their condition can be different from older patients. Researchers want to collect detailed health information from young patients soon after their heart attack and follow them over time. They will use this information, along with advanced computer techniques, to create a tool that can help doctors predict who is at higher risk and improve how heart attacks are diagnosed and treated in young adults.
To join the study, participants need to be between 18 and 45 years old and have had a heart attack diagnosed within the last 24 hours. They also need to be able to give consent and have a life expectancy of more than one year. People with previous serious heart problems, pregnancy, certain mental health issues, or other severe medical conditions won’t be eligible. If you join, you can expect to share your medical information and have regular check-ins so researchers can learn more about what affects recovery and long-term health after a heart attack in young adults. This study is not yet recruiting, but it aims to improve care and outcomes for younger people who experience this serious condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age between 18 and 45 years (inclusive of 18 and 45 years);
- • 2. Meeting the diagnostic criteria for acute myocardial infarction (including both ST-elevation myocardial infarction and non-ST-elevation myocardial infarction);
- • 3. Presenting for medical attention within 24 hours of symptom onset;
- • 4. The subject (or their legal representative) is willing and able to sign the informed consent form (for the prospective follow-up portion);
- • 5. Life expectancy greater than 1 year.
- Exclusion Criteria:
- • (1) History of prior old myocardial infarction, severe valvular heart disease, or heart failure; (2) Pregnancy or lactation; (3) Mental disorders or other conditions that prevent cooperation with treatment; (4) Concomitant severe infection, inflammatory or immunological biomarker changes unrelated to AMI, trauma, or recent major surgery.
About China Japan Friendship Hospital
China-Japan Friendship Hospital is a leading clinical research institution dedicated to advancing healthcare through innovative medical research and trials. Established as a collaborative effort between China and Japan, the hospital integrates cutting-edge technology with traditional medical practices, fostering a multidisciplinary approach to patient care and clinical studies. The institution is committed to enhancing therapeutic outcomes and improving patient safety while adhering to rigorous ethical standards. With a diverse team of experienced healthcare professionals and researchers, China-Japan Friendship Hospital plays a pivotal role in addressing global health challenges and contributing to medical knowledge through its extensive clinical trial programs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported